跳至主要内容
临床试验/ACTRN12619000494134
ACTRN12619000494134尚未招募3 期

Does intermittent infusion of lidocaine, magnesium sulphate and ketamine provide sustained analgesia in the treatment of neuropathic pain, Chronic Regional Pain Syndrome and fibromyalgia. A pilot study.

Daniel Ellyard0 个研究点目标入组 30 人开始时间: 2019年3月26日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Age > 18 years
  • Peripheral neuropathic pain (painful peripheral polyneuropathy, post herpetic neuralgia, trigeminal neuralgia, post surgical, post traumatic) OR Complex Regional Pain Syndrome (CRPS) OR Fibromyalgia
  • Average pain intensity greater than or equal to 6/10 despite oral analgesic medications

排除标准

  • - Pregnancy or breastfeeding
  • - History of seizure disorder
  • -Conduction abnormality on 12 lead ECG – PR >200ms, QRS >120ms, QTc >440ms
  • - Heart Failure – NYHA III / IV
  • - Chronic Liver Impairment – albumin < 30g/L OR INR >1.3
  • - Chronic Renal Impairment - eGFR <60ml/min/1.73m2
  • - Cognitive impairment deemed sufficient enough to preclude informed consent
  • - English language deemed insufficient to enable informed consent
  • - Known allergy or intolerance of proposed study medications
  • - Ongoing compensation/litigation claims

研究者

发起方
Daniel Ellyard

相似试验